STOCKHOLM, April 7, 2026 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of AI-based diagnostic solutions for skin disorders, today announced a significant milestone ...
Net sales were TSEK 12,475 (8,598), +45%, cleared for currency effects +57%. The loss after tax was TSEK 25,300 (21,677). The loss per share was SEK 0.06 (0.10). The cash flow from current operations ...
STOCKHOLM, Nov. 12, 2019 /PRNewswire/ -- SciBase a leading developer of electrical impedance spectroscopy systems in dermatology, announced today that The Kimberly and Eric J. Waldman Department of ...
Castle Biosciences (NASDAQ:CSTL) has partnered with SciBase Holding AB to develop a diagnostic test aimed at forecasting flare-ups in individuals suffering from atopic dermatitis. The agreement will ...
STOCKHOLM, March 10, 2026 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of AI-based diagnostic solutions for skin disorders, is pleased to announce the publication of ...
STOCKHOLM, Jan. 9, 2026 /PRNewswire/ -- The Board of Directors of SciBase Holding AB (publ) ("SciBase" or the "Company") publishes information documents in connection with the rights issue of shares ...
STOCKHOLM--(BUSINESS WIRE)--SciBase (STO:SCIB), who in June of this year took over the manufacturing of their single-use electrode from Ginolis, has appointed Anna Danström as Supply Chain & ...
“We are excited about the technology that SciBase has developed to date and the opportunity to leverage this technology to advance the care of patients with dermatological diseases. We believe this is ...
STOCKHOLM--(BUSINESS WIRE)--Regulatory News: SciBase (STO:SCIB) The interest in and acceptance of SciBase’s method for early detection of malignant melanoma is increasing, which is demonstrated by the ...
Higher Sensitivity: EIS captured early, and subtle structural changes not detected by TEWL measurement, highlighting its value for quantifying skin barrier impairment and complementing established ...
Oct 1 -Dec 31 Jan 1 -Dec 31 THE GROUP 2025 2024* 2025 2024* Net sales, SEK ths 12 475 8 598 40 461 29 705 Gross margin, % 63,0 % 68,5 % 67,0 % 71,0 % Equity/Asset ratio, % 12,8 % 59,4 % 12,8 % 59,4 % ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results